EirGenix Revenue

EirGenix had revenue of 229.00M TWD in the quarter ending September 30, 2025, a decrease of -7.74%. This brings the company's revenue in the last twelve months to 936.18M, down -20.05% year-over-year. In the year 2024, EirGenix had annual revenue of 1.01B, down -1.34%.

Revenue (ttm)

936.18M

Revenue Growth

-20.05%

P/S Ratio

24.31

Revenue / Employee

936.18K

Employees

1,000

Market Cap

22.76B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.01B	-13.69M	-1.34%
Dec 31, 2023	1.02B	-458.36M	-30.95%
Dec 31, 2022	1.48B	-216.34M	-12.75%
Dec 31, 2021	1.70B	625.52M	58.36%
Dec 31, 2020	1.07B	595.75M	125.14%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Caliway Biopharmaceuticals	34.99M
PharmaEssentia	13.82B
Lotus Pharmaceutical	18.66B
Bora Pharmaceuticals Co., LTD.	21.10B
Oneness Biotech	117.33M
Lumosa Therapeutics	42.59M
Center Laboratories	1.57B
Pegavision	6.90B

Revenue Rankings